PCR-based clonality detection in angioimmunoblastic T-cell lymphoma

CLINICAL PRESENTATION, DIAGNOSIS, AND MANAGEMENT OF LYMPHOID MALIGNANCIES , , ,

Yu.V. Sidorova, Ye.Ye. Nikulina, N.G. Chernova, L.G. Gorenkova, Ye.A. Gilyazitdinova, S.K. Kravchenko, A.M. Kovrigina, and A.B. Sudarikov

Hematology Research Center, RF Ministry of Health, Moscow, Russian Federation

ABSTRACT

In this article, we discuss the issues of angioimmunoblastic T-cell lymphoma diagnosis, particularly the PCR-based methods of clonality detection. Assessments of T-and B-cell clonality was based on TCRG (Vg-Jg), TCRB (Vb-Jb, Db-Jb), IGH (FR1, FR2, and FR3), IGK (Vk-Jk, Vk/intron-Kde), or IGL (Vl-Jl) gene rearrangements in 15 patients. Clonal TCRG gene rearrangements were found in 66.7 % of primary biopsy samples. The combined use of primers for TCRG and TCRB gene rearrangements confirmed T-cell monoclonal population in most cases (86.7 %). The rate of B-cell clonality detection was 26.6 %. The presence of B-cell clones was not associated with monoclonal secretion in the blood or detecting Epstein-Barr virus positive B-cells in the biopsy samples. PCR-based clonality analysis is an important step in diagnosis of angioimmunoblastic T-cell lymphoma that enables identifying monoclonal origin of T-lymphocytes in most cases. However, when interpreting the results obtained by this method, it is necessary to consider the possibility of detecting B-cell monoclonal products of unclear origin.

Keywords: angioimmunoblastic T-cell lymphoma, PCR, clonality, T-cell antigen receptor

Read in PDF (RUS)pdficon

REFERENCES

  1. Swerdlow S.H., Campo E., Harris N.L. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2008.
  2. Mourand N., Mounier N., Briere J. et al. Clinical, biologic and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials. Blood 2008; 111: 4463–70.
  3. Dogan A., Attygalle A.D., Kyriakou C. Angioimunoblastic T-cell lymphoma. Br. J. Haematol. 2003; 121: 681–91.
  4. Стефанов Д.Н., Ковригина А.М., Поддубная А.М. Новая концепция происхождения ангиоиммунобластной Т-клеточной лимфомы: от молеку- лярной биологии к терапии. Бюл. СО РАМН 2011; 31(2): 14–9. [Stefanov D.N., Kovrigina A.M., Poddubnaya A.M. New concept of origin of angioimmublastic T-cell lymphoma; from moleculat biology to therapy. Byul. SO RAMN 2011; 31(2): 14–9. (In Russ.)].
  5. Weiss L.M., Jaffe E.S., Liu X.F. et al. Detection and localization of EpsteinBarr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992; 79: 1789–95.
  6. Dupuis J., Boye K., Martin N. et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL). A new diagnostic marker providing evidence that AITL derives from follicular helper T-cells. Am. J. Surg. Pathol. 2006; 30: 490–4.
  7. Attygalle A., Al Jehani R., Diss T.C. et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99: 627–33.
  8. de Leval L., Rickman D.S., Thielen C. et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T cells (TFH). Blood 2007; 109: 4952–63.
  9. Yu H., Shahsafaei A., Dorfman D. Germinal-center T-helper cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am. J. Clin. Pathol. 2009; 131: 33–41.
  10. Lachenal F., Berger F., Ghesquieres H. et al. Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine (Baltimore) 2007; 86(5): 282–92.
  11. Zaki M.A., Wada N., Kohara M. et al. Presence of B-cell clones in T-cell lymphoma. Eur. J. Haematol. 2011; 86(5): 412–9.
  12. Синицына М.Н., Стефанов Д.Н., Захарова Е.С. и др. Изучение морфоиммуногистохимических особенностей и В-клеточной клональ- ности при ангиоиммунобластной Т-клеточной лимфоме. Злокачественные лимфомы. М.: Медиа Медика, 2010: 51. [Sinitsyna M.N., Stefanov D.N., Zakharova Ye.S., et al. Izucheniye morfoimmunogistokhimicheskikh osobennostey i B-kletochnoy klonalnosti pri angioimmunoblastnoy T-kletochnoy limfome. Zlokachestvennye limfomy (Studies of morphoimmunohistochemical features and B-cell clonality in angioimmunoblastic T-cell lymphoma. Malignant lymphomas). M.: Media Medika, 2010: 51.
  13. van Dongen J.J., Wolvers-Tettero I.L. Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin. Chem. Acta 1991; 198(1–2): 93–174.
  14. Theriault C., Galoin S., Valmary S. et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod. Pathol. 2000; 13(12): 1269–79.
  15. Higgins J.P., van de Rijn M., Jones C.D., Zehnder J.L., Warnke R.A. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am. J. Clin. Pathol. 2000; 114: 236–47.
  16. Lome-Maldonado C., Canioni D., Hermine O. et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with EpsteinBarr virus infection. A different subtype of AILD-TL? Leukemia 2002; 16: 2134–41.
  17. Tan B.T., Warnke R.A., Arber D.A. The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J. Mol. Diagn. 2006; 8(4): 466–75.
  18. Xu Y., McKenna R.W., Hoang M.P., Collins R.H., Kroft S.H. Composite angioimmunoblastic T-cell lymphoma and diffuse large B cell lymphoma: a case report and review of the literature. Am. J. Clin. Pathol. 2002; 118: 848–54.
  19. Сидорова Ю.В., Сорокина Т.В., Бидерман Б.В. и др. Определение минимальной остаточной болезни у больных В-клеточным хроническим лимфолейкозом методом пациент-специфичной ПЦР. Клин. лаб. диаг. 2011; 12: 22–35.  [Sidorova Yu.V., Sorokina T.V., Biderman B.V., et al. Detection of minimal residual disease in patients with B-cell chronic lymphocytic leukemia using patient-specific PCR. Klin. lab. diag. 2011; 12: 22–35. (In Russ.)]
  20. Wu L., Patten N., Yamashiro C.T., Chui B. Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues. Appl. Immunohistochem. Mol. Morphol. 2002; 10: 269–74.
  21. Coombs N.J., Gough A.C., Primrose J.N. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucl. Acids Res. 1999; 27: e 12.
  22. Sidorova J.V., Biderman B.V., Nikulina E.E., Sudarikov A.B. A simple and efficient method for DNA extraction from skin and paraffin-embedded tissues applicable to T-cell clonality assays. Exp. Dermatol. 2012; 21(1): 57–60.
  23. Dongen J.J., Langerak A.W., Bruggemann M. et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17(12): 2257–317.
  24. Willenbrock K., Renne C., Gaulard P., Hansmann M.L. In angioimmunoblastic T-cell lymphoma neoplastic T-cells may be a minor cell population. A molecular single-cell and immunohistochemical study. Virchows Arch. 2005; 446: 15–20.
  25. Zhang D., Saunders C.J., Zhao W., Davis M., Cunningham M.T. The clonality of CD3+ CD10+ T cells in angioimmunoblastic T cell lymphoma, B cell lymphoma, and reactive lymphoid hyperplasia. Am. J. Hematol. 2009; 84(9): 606–8.